ENDO 2021 Plenaries

November 05, 2020

Our outstanding slate of world-renowned plenary speakers will showcase the most cutting-edge advances on research and medicine, with presentations spanning the spectrum of science, clinical care, and social implications. Sessions include: 

Presidential Plenary: Big Data and the Future of Endocrine Research

  • Precisely Practicing Medicine from 700 Trillion Points of Data
    Atul J. Butte, MD, PhD—University of California, San Francisco, San Francisco, CA, USA
  • Diabetes Research in the Era of Big Data: The NIDDK Perspective
    Griffin Rodgers, MD—National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA

Presidential Plenary: The Impact of Basic Tissue Engineering and the Basic Biology of GPCRs in Emerging Therapies

  • Synthetic Hydrogels as Engineered Niches in Regenerative Medicine
    Andrés Garcia, PhD—Georgia Institute of Technology, Atlanta, Georgia, USA
  • Structural Insights Into G Protein Coupled Receptor Activation: Implications for Drug Discovery
    Brian Kobilka, MD—Stanford University, Stanford, CA, USA

Bridging the Translational Divide: Successes in Bench to Bedside

  • The Incretin Revolution: Lizard Secrets and Peptide Innovation Change the Management of Diabetes
    Daniel Drucker, MD, Lunenfeld-Tanenbaum Research Institute, University of Toronto Mt. Sinai Hospital, Toronto, Canada
  • Genetic Protection from Lipid Accumulation: A Journey from Plaque to Pate
    Helen Hobbs, MD, University of Texas Southwestern Medical Center, Dallas, TX, USA

A Deep Dive Into Development and Cancer

  • Cytoskeletal Methylation: A New Cancer Target for the Epigenetic Machinery Outside the Nucleus
    Cheryl Walker, Baylor College of Medicine, Houston, TX, USA
  • Understanding Spermatogonial Stem Cells and Male Puberty at the Single-Cell and Genomic Level
    Bradley Cairns, PhD, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA

Treating Type 2 Diabetes: New Approaches for an Old Foe

  • A Hepato-Centric View of Diabetes Therapy
    Adrian Vella, MD, FRCP, Mayo Clinic, Rochester, MN, USA
  • Hormonal Hybrids for Diabetes and Obesity
    Matthias Tschöp, MD, Helmholtz Zentrum Munchen, Germany

What Does Your Gut Tell You? How the Microbiome Modulates Metabolism

  • Multi-Omics Approaches Define New Regulatory Nodes in Cardiometabolic Disease Pathogenesis
    Christopher Newgard, PhD, Duke University, Durham, NC, USA
  • The Gut Microbiome: Connections Between Nutrient Sensing, Glucose, and Disease
    Tony Lam, PhD, Toronto General Hospital and University of Toronto, Canada
Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!